Open access · OA
via OpenAlex
Hematopoietic Stem Cells with High Proliferative Potential
Dane R. Boggs, Sallie S. Boggs, Debra Saxe, Lora A. Gress, Don R. Canfield
Journal of Clinical Investigation · 1982 · ▲ 144 citations
Abstract
THIS STUDY WAS DESIGNED TO APPROACH TWO PRIMARY QUESTIONS CONCERNING HEMATOPOIETIC STEM CELLS (HSC) IN MICE: what is the concentration of HSC with extensive proliferative potential in marrow, and how long can an HSC continue to function in an intact animal? The assay system was the W/W(v) mouse, a mouse with an inherited HSC defect, reflected in a reduction in all myeloid tissue and most particularly in a macrocytic anemia.A single chromosomally marked HSC will reconstitute the defective hematopoietic system of the W/W(v). The concentration of HSC in normal littermate (+/+) marrow was assayed by limiting dilution calculation using cure of W/W(v) as an end point (correction of anemia and erythrocytes' macrocytosis) and found to be approximately 10/10(5). This is significantly less than spleen colony forming cell (CFU-S) concentration: approximately 220/10(5) in +/+ and ranging from 50 to 270/10(5) in various other studies. Blood values were studied at selected intervals for as long as 26 mo. Of 24 initially cured mice, which were observed for at least 2 yr, 75% remained cured. However, of all cured mice, 17 lost the cure, returning to a macrocytic anemic state. Cured mice had normal numbers of nucleated and granulocytic cells per humerus and a normal concentration of CFU-S. However, cure of secondary W/W(v) recipients by this marrow was inefficient compared with the original +/+ marrow. These studies suggest the CFU-S assay over-estimates extensively proliferating HSC or perhaps does not assay such a cell. A single such HSC can not only cure a W/W(v), but can sustain the cure for 2 yr or more, despite a relative deficit of cells capable of curing other W/W(v). However, the duration of sustained cure may be finite.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1172/jci110611
- Canonical
- link ↗
- Fetched
- 2026-06-11 MST
Cite this
APA
Boggs, D.R., Boggs, S.S., Saxe, D., Gress, L.A., & Canfield, D.R. (1982). Hematopoietic Stem Cells with High Proliferative Potential. <em>Journal of Clinical Investigation</em>. https://doi.org/10.1172/jci110611
Vancouver
Boggs DR, Boggs SS, Saxe D, Gress LA, Canfield DR. Hematopoietic Stem Cells with High Proliferative Potential. Journal of Clinical Investigation. 1982. doi:10.1172/jci110611.
BibTeX
@article{dane1982Hemato,
title = {Hematopoietic Stem Cells with High Proliferative Potential},
author = {Dane R. Boggs and Sallie S. Boggs and Debra Saxe and Lora A. Gress and Don R. Canfield},
journal = {Journal of Clinical Investigation},
year = {1982},
doi = {10.1172/jci110611},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Cell Biochemistry and Function 2020
Citation only
Ageing and mesenchymal stem cells derived exosomes: Molecular insight and challenges
Blood 2003
Open access · OA
Homeostasis and regeneration of the hematopoietic stem cell pool are altered in SHIP-deficient mice
Journal of Clinical Medicine 2014
Open access · CC-BY
Adult Stem Cells and Diseases of Aging
Annals of the New York Academy of Sciences 2003
Citation only
Telomeres in Hematopoietic Stem Cells
Aging Cell 2011
Citation only
Rapamycin and other longevity‐promoting compounds enhance the generation of mouse induced pluripotent stem cells
Bioengineering 2024
Open access · CC-BY